NEW YORK, November 1, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts' Corner announced new research reports highlighting UnitedHealth Group Inc. (NYSE: UNH), Mylan Inc. (NASDAQ: MYL), Chemed Corporation (NYSE: CHE), C.R. Bard, Inc. (NYSE: BCR), and Universal Health Services, Inc. (NYSE: UHS). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
UnitedHealth Group Inc. Research Report
On October 22, 2013, UnitedHealth Group Inc. (UnitedHealth Group) reported that as per a research published by the journal Pediatric Obesity (September 2013), overweight and obese children and teens who participated in JOIN for ME, a community-based, pediatric-obesity lifestyle-intervention program developed by UnitedHealth Group's UnitedHealth Center for Health Reform & Modernization, were able to continue losing excess weight and improve their health and quality of life one year after the program had ended. In addition, the Company informed that JOIN for ME helped reduce the percentage of children who met criteria for obesity or extreme obesity and also enabled parents of participating children to achieve small, statistically significant weight reductions. Deneen Vojta, M.D. a physician executive at UnitedHealth Group and one of the study's principal investigators, said, "This study is the first to document long-term outcomes in a community-based program developed to help kids reduce excess weight, and we are pleased that the results show a statistically significant improvement in weight outcomes among participants." The Full Research Report on UnitedHealth Group Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/73e5_UNH]
Mylan Inc. Research Report
On October 29, 2013, Mylan Inc.'s (Mylan) stock gained 1.07%, ending the day at $38.65. Over the previous three trading sessions, Mylan's shares gained 0.42%, compared to the Nasdaq Composite which gained 0.60% during the same period. The Full Research Report on Mylan Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/5a20_MYL]
Chemed Corporation Research Report
On October 28, 2013, Chemed Corporation (Chemed) reported its Q3 2013 financial results. During the quarter, the Company's service revenue and sales declined 3.8% YoY to $340.9 million. Net income was $17.4 million or $0.94 per diluted share, compared to $20.8 million or $1.07 per diluted share in Q3 2012, while adjusted diluted EPS stood at $1.36 compared to $1.28 in Q3 2012. The Company stated that for full-year 2013, it expects revenue (prior to Medicare Cap) to decline by approximately 1% YoY and adjusted diluted EPS to be in the range of $5.60 to $5.65. The Full Research Report on Chemed Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/4c0d_CHE]
C.R. Bard, Inc. Research Report
On October 22, 2013, C.R. Bard, Inc. (Bard) reported its Q3 2013 financial results. Net sales increased 4.9% YoY to $758.0 million during the quarter. Net income was $93.2 million or $1.15 per diluted share, compared to $129.3 million or $1.50 per diluted share in Q3 2012. Commenting on the results, Timothy M. Ring, Chairman and CEO of Bard, said, "We are pleased with the results this quarter, exceeding expectations on both the top and bottom line. Consistent with our plan, we continue to focus on shifting the mix of the portfolio to faster revenue growth through targeted investments and acquisitions. Our business development activities, together with the results this quarter and other recent events, represent important steps in helping us improve the growth profile of the business going forward." The Full Research Report on C.R. Bard, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/141e_BCR]
Universal Health Services, Inc. Research Report
On October 29, 2013, Universal Health Services, Inc. (UHS) reported its Q3 2013 financial results. The Company's net revenues increased 8.1% YoY to $1.8 billion during the quarter. Net income attributable to UHS was $114.6 million or $1.15 per diluted share, compared to $71.8 million or $0.73 per diluted share in Q3 2012. Adjusted net income attributable to the Company stood at $1.10 per diluted share, compared with $0.91 per diluted share in Q3 2012.The Company stated that for full-year 2013, it has revised its estimated range of adjusted net income attributable to UHS to be within $4.52 to $4.58 per diluted share range. The Full Research Report on Universal Health Services, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/7d77_UHS]
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner